MB-CART20.1 Lymphoma

· Miltenyi Biomedicine GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MB-CART20.1 Lymphoma, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: MB-CART20.1 Lymphoma [Phase 1, Phase 2]